Meenal Mehrotra

Title: Meenal Mehrotra: Innovator in Osteogenesis Imperfecta Treatment

Introduction

Meenal Mehrotra is a distinguished inventor based in Mount Pleasant, SC (US). She has made significant contributions to the field of medical research, particularly in the treatment of Osteogenesis Imperfecta (OI). Her innovative work focuses on enhancing bone remodeling through advanced cellular therapies.

Latest Patents

Meenal holds a patent for her invention titled "T regulatory (Treg) cell transplantation in osteogenesis imperfecta (OI)." This patent relates to compositions comprising induced T regulatory cells (iTregs), methods of making these compositions, and methods of using them to enhance bone remodeling in the treatment of OI. She has successfully developed a unique approach that could potentially transform the treatment landscape for patients suffering from this condition. She has 1 patent to her name.

Career Highlights

Meenal is currently associated with the MUSC Foundation for Research Development, where she continues to advance her research and innovations. Her work is characterized by a commitment to improving patient outcomes through scientific discovery and application.

Collaborations

Some of her notable coworkers include In-Hong Kang and Uday Baliga, who contribute to her research endeavors and collaborative projects.

Conclusion

Meenal Mehrotra's innovative work in the field of Osteogenesis Imperfecta treatment exemplifies the impact of dedicated research and invention. Her contributions are paving the way for new therapeutic strategies that could benefit many patients in need.